Local cost analysis needed before application of EPISTENT findings

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.252, 2000-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Decision-Theoretic Framework for the Application of Cost-Effectiveness Analysis in Regulatory Processes

By Baio Gianluca Russo Pierluigi

PharmacoEconomics, Vol. 27, Iss. 8, 2009-08 ,pp. : 645-655

Adis International

Access to resources Recommend Favorite

Risperidone cost study findings disputed

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 463, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Susceptibility testing needed before H. pylori eradication?

Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Screening before providing cetuximab cost saving

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 669, 2013-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Bisphosphonates: economic analysis in clinical trials needed

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 332, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite